help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-0881
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canals, I.
Right arrow Articles by Gomis, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canals, I.
Right arrow Articles by Gomis, R.
Endocrinology Vol. 150, No. 2 642-650
Copyright © 2009 by The Endocrine Society

A Functional Leptin System Is Essential for Sodium Tungstate Antiobesity Action

Ignasi Canals, María C. Carmona, Marta Amigó, Albert Barbera, Analía Bortolozzi, Francesc Artigas and Ramon Gomis

Diabetes and Obesity Laboratory (I.C., M.C.C., M.A., A.Ba., R.G.), Endocrinology and Nutrition Unit, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Hospital Clinic de Barcelona, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (M.A., R.G.), and Department of Neurochemistry and Neuropharmacology (A.Bo.), Institut d’Investigacions Biomèdiques de Barcelona (Consejo Superior de Investigacíones Científicas), Institut d’Investigacions Biomèdiques August Pi i Sunyer, E-08036 Barcelona, Spain

Address all correspondence and requests for reprints to: Ramon Gomis, Endocrinology and Nutrition Unit, Hospital Clínic de Barcelona, Villarroel 170, E-08036 Barcelona, Spain. E-mail: rgomis{at}clinic.ub.es.

Sodium tungstate is a novel agent in the treatment of obesity. In diet-induced obese rats, it is able to reduce body weight gain by increasing energy expenditure. This study evaluated the role of leptin, a key regulator of energy homeostasis, in the tungstate antiobesity effect. Leptin receptor-deficient Zucker fa/fa rats and leptin-deficient ob/ob mice were treated with tungstate. In lean animals, tungstate administration reduced body weight gain and food intake and increased energy expenditure. However, in animals with deficiencies in the leptin system, treatment did not modify these parameters. In ob/ob mice in which leptin deficiency was restored through adipose tissue transplantation, treatment restored the tungstate-induced body weight gain and food intake reduction as well as energy expenditure increase. Furthermore, in animals in which tungstate administration increased energy expenditure, changes in the expression of key genes involved in brown adipose tissue thermogenesis were detected. Finally, the gene expression of the hypothalamic neuropeptides, Npy, Agrp, and Cart, involved in the leptin regulation of energy homeostasis, was also modified by tungstate in a leptin-dependent manner. In summary, the results indicate that the effectiveness of tungstate in reducing body weight gain is completely dependent on a functional leptin system.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society